End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,615 MXN | +20.46% | -.--% | -.--% |
05/06 | Collective bargaining partners in the chemical industry adjourn again | DP |
31/05 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
Sales 2024 * | 6.14B 6.69B 117B 557B | Sales 2025 * | 6.6B 7.19B 126B 600B | Capitalization | 5.02B 5.47B 95.47B 456B |
---|---|---|---|---|---|
Net income 2024 * | 225M 245M 4.28B 20.44B | Net income 2025 * | 413M 450M 7.86B 37.51B | EV / Sales 2024 * | 0.86 x |
Net Debt 2024 * | 251M 274M 4.78B 22.83B | Net Debt 2025 * | 197M 215M 3.75B 17.89B | EV / Sales 2025 * | 0.79 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
12.5
x | Employees | 16,425 |
Yield 2024 * |
2.44% | Yield 2025 * |
4.02% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
1 day | +20.46% |
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 01/15/01 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 08/08/08 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 08/08/08 |
Susanne Weiss
BRD | Director/Board Member | 63 | 08/08/08 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.43% | 19.8B | |
+2.13% | 4.16B | |
+13.23% | 1.54B | |
-2.65% | 1.26B | |
+16.44% | 943M | |
-17.41% | 658M | |
-38.91% | 550M | |
-22.36% | 274M | |
-6.04% | 252M |
- Stock Market
- Equities
- WCH Stock
- WCH N Stock